BSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.
Medplus Health Services Ltd: key numbers
- Share price
- ₹597.85
- Market cap
- ₹7,184 Cr
- Revenue (annual)
- ₹6,892 Cr
- Net profit (annual)
- ₹219.7 Cr
- P/E (TTM)
- 34.0×Sector 53.8×
- Promoter holding
- 40.19%+0.00% QoQ
- FII holding
- 12.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medplus Health Services Ltd
All →Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Medplus Health Services Board Meeting Date
MedPlus Health Services scheduled a board meeting for 6 November 2026 to consider a share buy-back. The trading window for designated persons closes from 30 October 2026.
Medplus Health Services Capital Structure Change
ICICI Prudential Mutual Fund disclosed under Regulation 29(2) that it bought 24,35,693 Medplus shares, lifting its stake to 9.21%. The acquisition was made in the open market, not off-market.
- Promoter stake change
- +1.97%
Medplus Health Services Earnings Call Transcript: Key Takeaways
Medplus reported Q2 revenue of ₹2,037.1 Cr with 21.3% pharmacy growth, but EBITDA margins were hit by state-mandated wage hikes.
- Call
- Guides 10% growth
Medplus Health Services Share Pledge
Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).
Medplus Health Services Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,037cr (+21.3% YoY), operating EBITDA ₹98cr (4.8% margin), reported PAT ₹56cr (+1% YoY). Store expansion continues; no explicit guidance given.
Other board meeting outcome announcements
All →Niva Bupa Health Insurance Company Board Meeting Outcome
Niva Bupa Health Insurance Company's Board approved amendments and the consolidation of its PIT policies. The updated policy integrates UPSI fair disclosure and leak inquiry procedures into a single framework.
K Z Leasing & Finance Board Meeting Outcome
KZ Leasing & Finance's board adopted unaudited results for Q1 and H1 ending September 2026. No financial data is enclosed in this intimation.
Kasturi Metal Composite Board Meeting Outcome
Kasturi Metal Composite's board approved voluntarily publishing quarterly financial results from the quarter ending December 31, 2026. The mandatory SME filings remain half-yearly.
Tanvi Foods (India) Board Meeting Outcome
Tanvi Foods (India) Limited re-appointed Ms. Jonnada Vaghira Kumari as Non-Executive Independent Director for 60 months, effective 3 November 2026. This is a routine board-level director re-appointment.
Jyoti Structures Board Meeting Outcome
Jyoti Structures reconstituted its Nomination and Remuneration Committee and Risk Management Committee after its November 3, 2026 board meeting. The filing lists the revised members and chairpersons only.
Dhampure Specialty Sugars Board Meeting Outcome
Dhampure Speciality Sugars reconstituted its Audit, Nomination & Remuneration and Stakeholders' Relationship Committees effective 3 Nov 2026. No money or business event is involved.